Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC
Krishnendu Pal,* Vijay Sagar Madamsetty,* Shamit Kumar Dutta, Debabrata MukhopadhyayDepartment of Biochemistry and Molecular Biology, Mayo Clinic Florida, Jacksonville, FL 32224, USA*These authors contributed equally to this workBackground: Renal cell carcinoma (RCC) is notorious for its resistance...
Guardado en:
Autores principales: | Pal K, Madamsetty VS, Dutta SK, Mukhopadhyay D |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f6e68567f9d44a2a9f4e4c88209baa0a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer
por: Wang S, et al.
Publicado: (2021) -
Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC
por: Kong L, et al.
Publicado: (2020) -
Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer
por: Wang Y, et al.
Publicado: (2019) -
Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature
por: Peri M, et al.
Publicado: (2020) -
Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
por: Cong Luo, et al.
Publicado: (2021)